<DOC>
	<DOCNO>NCT02034591</DOCNO>
	<brief_summary>The purpose study assess bioavailability Apixaban oral solution administer Nasogastric Tube ( NGT ) presence BoostÂ® Plus Apixaban administer crushed tablet nasogastric tube relative Apixaban solution administer orally healthy subject .</brief_summary>
	<brief_title>Phase 1 Oral Solution Crushed Tablet Relative Bioavailability Study Apixaban When Administered Through Nasogastric Tube Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination Any significant acute chronic medical illness Any history evidence abnormal bleed coagulation disorder , intracranial hemorrhage , abnormal bleeding ( include heavy menstrual bleeding result anemia within past 1 year ) coagulation disorder first degree relative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>